From gut to brain: NUS scientists engineer bacteria to treat severe liver-related brain dysfunction
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Jun-2026 08:15 ET (9-Jun-2026 12:15 GMT/UTC)
Scientists from the National University of Singapore have successfully engineered a naturally occurring beneficial gut bacterium into a programmable “living medicine” to treat hepatic encephalopathy (HE), a severe brain dysfunction linked to liver failure. The therapy combines two engineered gut-bacteria strains: one absorbs excess gut ammonia and converts it into nutrients lacking in HE patients, while the other reduces ammonia production. Compared with a standard HE antibiotic, the cocktail achieved stronger improvements in anxiety and short-term memory, while also reduced inflammation in the brain.
Cotton genome editing, especially in elite varieties, has proven difficult. Now, in a study published in The Crop Journal, researchers from China have successfully demonstrated CRISPR/Cas genome editing in nonregenerative cotton via sexual hybridization. This work opens up a novel technical avenue for the genetic improvement of elite cotton varieties that are recalcitrant to tissue culture, advancing agriculture and biotechnology.
Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, functional fragments rather than following the standard blueprint. This process, newly termed as “RNA dicing,” enables the production of a truncated form of the JAK1 protein that remains highly active and can promote tumor growth, particularly when normal gene function is disrupted. The finding challenges conventional views of how genetic information is translated and points to a previously unrecognized mechanism that could influence cancer progression and response to targeted therapies.
Background
Ticks are key vectors of zoonotic diseases in the Northern Hemisphere, including China, yet surveillance and public awareness remain limited. While global studies address risk perception, similar research in China, especially with spatial or longitudinal detail, is scarce. This study assesses tick-borne disease risk perception, influencing factors, and spatial variation in Northeast China and Nei Mongol Zizhiqu (also known as Inner Mongolia Autonomous Region) to inform targeted interventions.
Methods
In 2019, a cross-sectional questionnaire surveyed 4000 adults in Heilongjiang, Jilin, Liaoning, and Nei Mongol Zizhiqu using multi-stage sampling. Knowledge was assessed in four domains: tick biology/ecology, bite treatment, tick-borne diseases, and bite prevention, alongside socio-demographic and behavioral data. Descriptive statistics and multiple logistic regression identified knowledge levels and associated factors.
Results
Knowledge of tick biology was relatively high (1830/4000, 45.8% with high knowledge), but awareness of bite treatment, diseases, and especially prevention was low (31.5% with high tick-borne disease knowledge; 21.6% with high prevention knowledge), even among high-risk groups. Urban residents had higher knowledge than those in rural or remote areas. Frequent woodland visits and prior tick bites increased knowledge of tick biology (regression coefficients: 0.311 and 0.387, both P < 0.001) but not prevention. Education and outdoor activity showed mixed associations with knowledge domains.
Conclusion
Major gaps exist in public knowledge of tick-borne diseases, particularly regarding prevention, with notable disparities across regions and risk groups. Targeted, region-specific interventions are urgently needed to improve awareness and protection, especially in high-risk and low-awareness areas.
A joint research group consisting of Hikaru Ichida, a doctoral student in the Division of Nano Life Science, Graduate School of Frontier Science Initiative, Kanazawa University; Kosuke Mizuno, currently a Postdoctoral Researcher at the Institute for Protein Research, The University of Osaka; Professor Noriyuki Kodera and Associate Professor Holger Flechsig of the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University; and Associate Professor Satoshi Toda of the Institute for Protein Research, The University of Osaka, has succeeded in visualizing the structural dynamics underlying how the serum protein Afamin stabilizes and transports Wnt3a, a lipid-modified signaling molecule. The study also showed that stable binding between these two molecules depends on both a hydrophobic pocket that accommodates Wnt3a and the structural integrity of Afamin. Wnt proteins are essential molecules that help the body develop properly and maintain healthy tissues. However, because they do not dissolve well in water and are highly hydrophobic, they tend to be unstable in the body. This study has revealed part of the mechanism by which Wnt3a is stably transported with the help of another protein. These findings are expected to deepen our understanding of biological processes involving Wnt3a and may contribute in the future to the development of ex vivo tissue engineering technologies and regenerative medicine.
A new paper in Genome Biology and Evolution discovers that the endangered Mediterranean fin whale is not completely isolated from Atlantic groups. Both Atlantic and Mediterranean populations have declined for the past 200,000 years. Considering more recent threats to the whales, this finding has important implications for conservation, particularly considering increasing anthropogenic pressures.
Every stroke begins with a sudden interruption of blood flow in the brain. But what happens afterward—why neurons continue to lose function and die over the following days—has remained one of the most important unanswered questions in neuroscience.
A research team led by Director C. Justin LEE at the Center for Memory and Glioscience within the Institute for Basic Science (IBS), in collaboration with Professor RYU Seungjun of Eulji University, has now uncovered a previously unknown mechanism that drives this delayed brain damage. Their findings show that stroke is not only caused by the initial loss of blood flow, but also by a chain reaction within the brain that unfolds over time.Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered “undruggable,” opening the door to new treatments for prostate cancer and other serious diseases. Known as intrinsically disordered proteins, these molecular shapeshifters are extremely difficult to target with medication due to their flexible and ever-changing structure. They play a central role in a wide range of diseases—including cancer, neurodegenerative disorders, heart disease and autoimmune conditions—yet only a handful of medications currently exist that can target them. In a study published today in Nature Signal Transduction and Targeted Therapy, the researchers demonstrate a new approach for designing drugs that bind more strongly to these proteins and block their disease-causing activity. In some cases, the compounds they developed bound up to a million times more tightly than any previously reported.